Biocytogen Pharmaceuticals (Beijing) Co Ltd - Class H

NEW
HKSE:02315 (China)   Class H
HK$ 12.12 +0.44 (+3.77%) Apr 28
144.29
P/B:
5.41
Market Cap:
HK$ 4.81B ($ 620.07M)
Enterprise V:
HK$ 4.84B ($ 624.14M)
Volume:
177.00K
Avg Vol (2M):
236.18K
Trade In:
What is a stock summary page? Click here for an overview.
Volume:
177.00K
Avg Vol (2M):
236.18K

GF Value

Biocytogen Pharmaceuticals (Beijing) Co Ltd’s share price is HK$12.12. Its GF Value is HK$0. Based on the relationship between the current stock price and the GF Value, GuruFocus believes Biocytogen Pharmaceuticals (Beijing) Co Ltd stock is .

The GF Value represents the current intrinsic value of a stock derived from our proprietary algorithm. It is based primarily on the historical multiples of where the stocks have been traded and the future growth of the business, adjusted for the past returns and growth. The GF Value has been verified by backtesting and daily updated model portfolios.

GF Value Growth:

In addition to considering the current valuation, the growth potential of a company's value is equally important. Companies with faster growth rates tend to increase their value more quickly. Therefore, it's essential to look at the Price-to-Future GF Value ratios as well. The results are shown below:

Price: HK$12.12 GF Value Price/GF Value
Current HK$0 Infinity
Next FY1 End HK$0 Infinity
Next 12 Month HK$0 Infinity
Next FY2 End HK$0 Infinity
Correlation Analysis
Summary:

GuruFocus performed a correlation analysis comparing Biocytogen Pharmaceuticals (Beijing) Co Ltd's stock price with key financial metrics: revenue per share, book value per share, EPS without NRI, and operating cash flow per share.

The findings reveal that Biocytogen Pharmaceuticals (Beijing) Co Ltd's stock price shows no significant correlation with any of these four metrics.

Historical Trends of Key Valuation Ratios
GF Value of Related Companies